デフォルト表紙
市場調査レポート
商品コード
1470905

止血剤の市場:タイプ、製剤、用途別-2024年~2030年の世界予測

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
止血剤の市場:タイプ、製剤、用途別-2024年~2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血剤市場規模は2023年に32億3,000万米ドルと推計され、2024年には34億2,000万米ドルに達し、CAGR 5.65%で2030年には47億5,000万米ドルに達すると予測されています。

止血剤は、外科手術や外傷時の出血を制御、予防、止血するために設計されたさまざまな医療機器や製品です。これらの医療機器は出血を管理し、合併症のリスクを軽減しながら適切な組織治癒を促進する重要な役割を担っています。止血剤は、心臓血管外科、一般外科、整形外科、神経外科、婦人科外科、歯科外科など、多くの外科専門分野で応用されています。高齢化に伴う慢性疾患の増加により、効果的な出血管理ソリューションを必要とする手術の需要が高まっており、その結果、多様な止血剤の利用が拡大しています。さらに、低侵襲手術への志向の高まりと、手術インフラを改善するための政府機関やヘルスケア団体による投資の増加が、止血剤の使用率を高めています。画期的な製品の開発に伴う高い研究開発コストと止血剤による汚染の高いリスクが市場成長の妨げとなっています。効果的な出血コントロールを提供しながら副作用を最小限に抑える、市場ベンダーによる生物学的適合性のある止血剤の開拓が進んでおり、市場成長の機会を生み出すと期待されています。

主な市場の統計
基準年[2023] 32億3,000万米ドル
予測年[2024] 34億2,000万米ドル
予測年 [2030] 47億5,000万米ドル
CAGR(%) 5.65%

タイプ出血を最小限に抑える効果の向上により、コンビネーション止血剤の使用が拡大

コラーゲンベースの止血剤は精製されたコラーゲンに由来し、優れた生体適合性と血小板凝集を開始させることにより血栓形成を促進する能力で知られています。これらの止血剤は、脳外科手術や眼科手術のような軟部組織やデリケートな構造を伴う手術に好んで使用されます。コンビネーション止血剤は、止血効果を高めるために相乗的に働く2つ以上の活性剤から構成されています。一般的に、コラーゲンベース、ゼラチンベース、トロンビンベースのような止血剤の利点を組み合わせた製品です。コンビネーション止血剤の需要は、複雑な外科手術中の出血性合併症を最小限に抑える効果が高まっているため増加しています。酸化再生セルロースベースの止血剤は、酸化再生プロセスを経た植物由来のセルロースから作られています。抗菌性を有し、血管と周辺組織の間に物理的なバリアを形成することで出血を効果的に抑制します。ORCベースの止血剤は、歯科手術、消化器外科手術、婦人科手術でよく使用されます。トロンビンベースの止血剤は活性成分としてヒトまたはウシのトロンビンを含んでおり、凝固カスケードを活性化し、迅速に血栓を形成します。心臓血管の手術や臓器移植など、従来の手技が有効でない、あるいは実用的でない出血のコントロールに特に有用です。コラーゲンベースの止血剤は生体適合性に優れ、デリケートな手術に好まれることが多いです。コンビネーション止血剤は相乗効果により、より高い効果を発揮します。ゼラチンベースの止血剤は、危機的状況における迅速な血液凝固能力が評価されています。ORCベースの止血剤は抗菌性を発揮し、出血コントロールのための物理的バリアを作り、トロンビンベースの止血剤は凝固カスケードを活性化し、迅速な血液凝固を形成します。

製剤化外科手術中の出血をコントロールし、予防するための粉末止血剤の可能性が高まっています。

マトリックスおよびゲル止血剤は生体適合性、吸収性材料であり、迅速な血栓形成を促進します。低侵襲手術のように、手術中に直接圧迫することが困難な場合に好まれます。粉末止血剤は、出血組織から体液を吸収し、血小板の凝集を促進します。適用が容易なため、一般外科、整形外科、心臓血管外科、脳神経外科など、さまざまな外科手術に適しています。シートおよびパッド 止血剤柔軟な生体吸収性材料であるため、不規則な創傷面への適合性が高いです。広い範囲をカバーする必要があり、縫合が困難な手術で使用されます。スポンジ止血剤は、様々な形状に成形しやすい高吸収性材料で、不規則な創傷腔に適しています。歯科、口腔外科、脳神経外科、心臓血管外科などでよく使用されています。マトリックス&ゲル止血剤は、手の届きにくい場所での迅速な血栓形成を可能にし、パウダー止血剤は、外科手術の専門分野を問わず簡単に使用できます。また、スポンジ止血剤は、不規則な創傷腔に優れた吸収性と成形性を提供します。

アプリケーション心臓血管外科手術における止血剤の重要な役割は、出血を防ぎ、手術結果を確実にすることです。

心臓血管外科手術では、動脈、静脈の血流が多く、出血を防ぐために効率的な止血材が必要とされます。止血剤は、その迅速な作用と効果的な止血を達成する能力により、これらの手術において広く好まれています。一般外科手術では、止血剤の使用は、盲腸やヘルニア修復などの手術中の創傷管理や最小限の出血を確保するために重要な役割を果たしています。婦人科手術では、子宮摘出術や子宮筋腫摘出術などの繊細な手技の際に、しばしば細心の注意を払って出血をコントロールする必要があります。止血剤は、このような手術の際に十分な止血を行いながら、癒着を効果的に最小限に抑えます。止血剤は、神経構造を保ちながら、このようなニーズに対応するために特別にデザインされています。人工関節置換術や骨折固定術などの整形外科手術では、緻密な骨や結合組織を切開するため、強力な止血剤が必要となります。皮膚移植やフラップ再建を含む再建手術では、出血量の管理が手術の成功に不可欠となります。止血剤は様々な組織に適応し、大きな傷を効果的に塞ぐことができるため、このような症例で好まれています。他の用途と比較して、心臓血管外科手術では高度な止血剤に対するニーズが高いです。

地域別の洞察

米国、カナダ、ブラジルを中心に、高度な医療施設の利用可能性が高まり、外科手術の件数が増加していることが、南北アメリカの止血剤市場の成長を拡大しています。American Society of Plastic Surgeonsによると、2022年には合計1,017,003件の再建手術が行われ、止血剤の使用が必要となった。カナダ、ドバイ、シンガポール、日本、英国における医療ツーリズムの新たな動向は、低侵襲外科手術の件数を拡大し、止血剤市場のプラットフォームを形成しています。メディカル・ツーリズム指数調査(MTA)によると、カナダは、他国から約1,400万人のアメリカ人を惹きつけている、好まれる旅行先の一つです。欧州各国のヘルスケア・インフラやテクノロジーの継続的な進歩と、欧州医薬品庁(EMA)などの規制機関による医療機器やヘルスケア・インフラの製造拡大に関する絶え間ない支援が、欧州市場を強化しています。中東・アフリカ地域は、医療費の増加と医療インフラの近代化に向けた政府の取り組みにより、有望な成長機会をもたらしています。サウジアラビア、アラブ首長国連邦、南アフリカなどの国々では、外科手術件数の増加に伴い、効果的な止血ソリューションのニーズが急増しています。さらに、インド、オーストラリア、中国、日本では、国内での医療機器製造を拡大するための政府資金が増加し、低侵襲手術に関連する認知度が高まっていることから、アジア太平洋地域の市場成長を後押しするものと期待されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは止血剤市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、止血剤市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.止血剤市場の市場規模および予測は?

2.止血剤市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.止血剤市場の技術動向と規制枠組みは?

4.止血剤市場における主要ベンダーの市場シェアは?

5.止血剤市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 外科的介入の必要性が高まっている慢性疾患の蔓延
      • 低侵襲手術への傾向の高まり
    • 抑制要因
      • 製品リコールの発生件数の増加
    • 機会
      • バイオポリマーベースの使い捨ての台頭止血剤
      • より効率的でターゲットを絞ったものを作るためのナノテクノロジーの統合止血剤
    • 課題
      • 止血剤ツールおよび試薬の使用に伴う感染および交差汚染のリスク
  • 市場セグメンテーション分析
    • タイプ:出血を最小限に抑える効果の向上により、組み合わせ止血剤の使用を拡大
    • 処方:外科的介入中の出血を抑制および予防するための粉末止血剤の成長可能性
    • 応用:心臓血管手術における失血防止と手術成功の保証における止血剤の重要な役割
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 止血剤の市場:タイプ別

  • コラーゲンベース止血剤
  • 組み合わせ止血剤
  • ゼラチンベース止血剤
  • 酸化再生セルロースベース止血剤
  • トロンビンベース止血剤

第7章 止血剤の市場:製剤別

  • マトリックス&ジェル止血剤
  • パウダー止血剤
  • シート&パッド止血剤
  • スポンジ止血剤

第8章 止血剤の市場:用途別

  • 心臓血管外科
  • 一般外科
  • 婦人科手術
  • 神経外科
  • 整形外科
  • 再建手術

第9章 南北アメリカの止血剤の市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の止血剤の市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの止血剤の市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
    • テレフレックス、心臓外科手術におけるQuikClot Control+止血デバイスの使用拡大についてFDAの承認を取得
    • バクスター、吸収性止血パウダー「PERCLOT」を発売
    • アルティビオン、パークロットのFDA承認を取得、バクスターへの移管を開始
    • オリンパス欧州 SE & Co. KGがエンドクロット社との提携を拡大し、止血剤を発売
    • ダーリン・イングレディエンツ、ブラジルのゼラチン・コラーゲン製造会社ジェルネックスの買収を完了
    • 重度の手術出血を抑えるキトサンベースの止血剤がFDAの認可を取得
    • アドバメディカ社、Ax-Surgi外科用止血材のFDA認可を発表
    • Medcura社、LifeGel吸収性外科用止血材で画期的デバイス指定を取得
    • メドトロニック社のネクパウダー内視鏡止血システムが米国FDAの認可を取得
    • Hemostasis LLC、Fiagon Medical Technologiesの買収を完了
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HEMOSTATS MARKET DYNAMICS
  • FIGURE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 113. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 119. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 125. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 137. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 155. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 175. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 181. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 187. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 199. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 205. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 211. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 217. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 223. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 229. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 235. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 241. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 247. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 253. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 265. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 277. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 283. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 298. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-961BA04A2E36

[192 Pages Report] The Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 5.65% to reach USD 4.75 billion by 2030.

The hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents. Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.23 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.65%

Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding

Collagen-based hemostats are derived from purified collagen; they are known for their excellent biocompatibility and ability to accelerate clot formation by initiating platelet aggregation. These hemostats are often preferred in surgeries involving soft tissues and delicate structures, such as neurosurgery and ophthalmic surgery. Combination hemostats consist of two or more active agents that work synergistically to enhance hemostatic efficacy. They typically combine the benefits of hemostats, such as collagen-based, gelatin-based, and thrombin-based products. The demand for combination hemostats is growing due to their increased effectiveness in minimizing bleeding complications during complex surgical procedures. Oxidized regenerated cellulose-based hemostats are made from plant-derived cellulose that undergoes oxidation and regeneration processes. They possess antimicrobial properties and effectively control bleeding by creating a physical barrier between blood vessels and surrounding tissues. ORC-based hemostats are often used in dental surgeries, gastrointestinal surgeries, and gynecological procedures. Thrombin-based hemostats contain human or bovine thrombin as their active ingredient, which activates the coagulation cascade, resulting in rapid clot formation. They are particularly useful in controlling bleeding where traditional techniques may be ineffective or impractical, such as cardiovascular surgeries or organ transplantations. The collagen-based hemostats provide excellent biocompatibility and are often preferred for delicate surgeries. Combination hemostats offer increased effectiveness due to their synergistic properties. Gelatin-based hemostats are valued for their rapid blood clotting ability in critical situations. ORC-based hemostats exhibit antimicrobial properties and create a physical barrier for bleeding control, while thrombin-based hemostats activate the coagulation cascade for rapid clot formation.

Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention

Matrix and gel hemostats are biocompatible, absorbable materials that facilitate rapid clot formation. They are preferred in situations where the application of direct pressure during surgery is difficult, such as in minimally invasive procedures. Powder hemostats work by absorbing fluid from bleeding tissue and enhancing platelet aggregation. Their ease of application makes them suitable for various surgical specialties, including general, orthopedic, cardiovascular, and neurosurgery. Sheet and pad hemostats are flexible bioabsorbable materials, allowing for better conformity to irregular wound surfaces. They are utilized in surgeries where larger areas need to be covered, and suturing is challenging. Sponge hemostats are highly absorbent materials easily molded into various shapes, making them suitable for irregular wound cavities. They are commonly used in dental and oral surgeries, as well as neurosurgery and cardiovascular surgery. Matrix & gel hemostats provide rapid clot formation in hard-to-reach areas, whereas powder hemostats offer easy application across surgical specialties. Sheet & pad hemostats conform to irregular wound surfaces covering larger areas; then, sponge hemostats provide excellent absorbency and moldability for irregular wound cavities.

Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes

Cardiovascular surgeries involve high blood flow, arteries, and veins, often requiring efficient hemostatic solutions to prevent excessive bleeding. Hemostats are widely preferred in these procedures due to their rapid action and ability to achieve effective hemostasis. In general surgery, the use of hemostats plays a significant role in wound management and ensuring minimum blood loss during procedures such as appendectomy and hernia repair. Gynecological surgeries often require meticulous control of bleeding during delicate procedures such as hysterectomy and myomectomy. Hemostats have effectively minimized adhesions while providing adequate hemostasis during these surgeries. Hemostats are specifically designed to address this need while preserving neural structures. Orthopedic surgeries, including joint replacements and fracture fixation, require robust hemostatic agents as they involve cutting through dense bone and connective tissues. In reconstructive surgery, which includes skin grafting and flap reconstruction, managing blood loss becomes critical for successful outcomes. Hemostatic agents are preferred in these cases due to their adaptability across different tissues and ability to seal large wounds effectively. Compared to other applications, cardiovascular surgeries show a higher need-based preference for advanced hemostatic agents.

Regional Insights

The growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations. Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Collagen-Based Hemostats
    • Combination Hemostats
    • Gelatin-Based Hemostats
    • Oxidized Regenerated Cellulose-Based Hemostats
    • Thrombin-Based Hemostats
  • Formulation
    • Matrix & Gel Hemostats
    • Powder Hemostats
    • Sheet & Pad Hemostats
    • Sponge Hemostats
  • Application
    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Reconstructive Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hemostats Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats Market?

3. What are the technology trends and regulatory frameworks in the Hemostats Market?

4. What is the market share of the leading vendors in the Hemostats Market?

5. Which modes and strategic moves are suitable for entering the Hemostats Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
    • 12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
    • 12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
    • 12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
    • 12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
    • 12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
    • 12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
    • 12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio